Clinical trial

Ibrance Real World Insights

NCT03159195

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-06-12

PhaseN/A

Study timeline

Study start (actual)2017-06-12Date precision: day

Registry last updated2025-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Malignant Neoplasm of Breastverified · MONDO: breast cancer

Interventions

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03159195 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.